- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
BioTime To Present At the Oppenheimer 26th Annual Healthcare Conference
BioTime, Inc.’s (NYSE MKT and TASE: BTX) co-chief executive officer will present at the Oppenheimer 26th Annual Healthcare Conference in New York City from December 8 to 9, 2015.
BioTime, Inc.’s (NYSE MKT and TASE: BTX) co-chief executive officer will present at the Oppenheimer 26th Annual Healthcare Conference in New York City from December 8 to 9, 2015.
According to the press release:
Mr. Mohanty will provide an overview of the Company and an update on product development in his presentation on December 8, 2015 at 3:55 pm ET/12:55 pm PT. Mr. Mohanty and Russell Skibsted, Chief Financial Officer, will also participate in one-on-one meetings with investors throughout the day.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.